2013
DOI: 10.1016/j.ejphar.2012.11.042
|View full text |Cite
|
Sign up to set email alerts
|

Protective effects of 17beta-estradiol on post-ischemic cardiac dysfunction and norepinephrine overflow through the non-genomic estrogen receptor/nitric oxide-mediated pathway in the rat heart

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
6
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 34 publications
2
6
0
Order By: Relevance
“…Estrogen was shown to have a role in cardioprotection against I/R injury. Short-term estrogen treatment (15 minutes before ischemia and 5 minutes at the beginning of reperfusion) improved heart function similar to that seen with pacing postconditioning 3, 103 . In addition, these beneficial effects of estrogen were not observed in the presence of a NOS inhibitor, suggesting that nitric oxide production via ER activation plays a key role in this process 103 .…”
Section: Membrane Delimited (Non-genomic) Signalingsupporting
confidence: 52%
See 1 more Smart Citation
“…Estrogen was shown to have a role in cardioprotection against I/R injury. Short-term estrogen treatment (15 minutes before ischemia and 5 minutes at the beginning of reperfusion) improved heart function similar to that seen with pacing postconditioning 3, 103 . In addition, these beneficial effects of estrogen were not observed in the presence of a NOS inhibitor, suggesting that nitric oxide production via ER activation plays a key role in this process 103 .…”
Section: Membrane Delimited (Non-genomic) Signalingsupporting
confidence: 52%
“…Short-term estrogen treatment (15 minutes before ischemia and 5 minutes at the beginning of reperfusion) improved heart function similar to that seen with pacing postconditioning 3, 103 . In addition, these beneficial effects of estrogen were not observed in the presence of a NOS inhibitor, suggesting that nitric oxide production via ER activation plays a key role in this process 103 . Also, there are a number of studies showing that estrogen prevents cardiac hypertrophy; in particular through ERβ 4, 104 .…”
Section: Membrane Delimited (Non-genomic) Signalingsupporting
confidence: 52%
“…The pathways involved differ with the severity of ischemia. In this stunning model, MPTP was not opened and so it cannot be involved in the cardioprotective effect of Gen. Possible pathways could be PI3K/Akt and its downstream effector eNOS, as described in PC and in the cardioprotection of estradiol via GPER . Nevertheless, the effects of Gen were unaffected by NOS inhibition with L‐NAME in our stunned rat hearts.…”
Section: Discussionmentioning
confidence: 74%
“…Finally, Gen could release nitric oxide, which is part of a cardioprotective mechanism mediated by the estrogenic receptor under estradiol stimulation . In order to evaluate this, the hearts were treated with the selective inhibitor of NO‐synthase L‐NAME before and during perfusion with Gen.…”
Section: Resultsmentioning
confidence: 99%
“…Natural estrogens include estrone (E 1 ), 17βestradiol (E 2 ) and estriol (E 3 ), and E 2 plays a particularly important role in the gonadal development and uptake of vitellogenin into oocytes (Gustafsson, 2003;Hess, 2003;Heldring et al, 2007;Hara et al, 2016;Liu et al, 2017) via nuclear estrogen receptors (ERs) (Auchus and Fuqua 1994;Fukumoto et al, 2013;Tsai and O'Malley, 1994). There are three reported isoforms of ER, namely ERα, ERβ and ERγ (Sabo-Attwood et al, 2004;Nagler et al, 2012), and only ERα is known to have a high affinity to estrogens in the ovary.…”
Section: Introductionmentioning
confidence: 99%